689
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Down-regulation of A20 mRNA expression in peripheral blood mononuclear cells from MDS patients

ORCID Icon, , , , & ORCID Icon
Article: 2330851 | Received 26 Feb 2024, Accepted 10 Mar 2024, Published online: 21 Mar 2024

References

  • Vegivinti CTR, Keesari PR, Veeraballi S, et al. Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review. Exp Hematol Oncol. 2023;12(1):60. doi: 10.1186/s40164-023-00422-1
  • Muto T, Walker CS, Choi K, et al. Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs. Nat Immunol. 2020;21(5):535–545. doi: 10.1038/s41590-020-0663-z
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi: 10.1182/blood-2016-03-643544
  • Kristinsson SY, Björkholm M, Hultcrantz M, et al. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol. 2011;29(21):2897–2903. doi: 10.1200/JCO.2011.34.8540
  • Choudhary GS, Pellagatti A, Agianian B, et al. Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations. Elife. 2022;11:e78136. doi: 10.7554/eLife.78136
  • Basiorka AA, McGraw KL, Eksioglu EA, et al. The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype. Blood. 2016;128(25):2960–2975. doi: 10.1182/blood-2016-07-730556
  • Ping Z, Chen S, Hermans SJF, et al. Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes. Leukemia. 2019;33(2):536–541. doi: 10.1038/s41375-018-0267-x
  • Li D, Wang L, Fan Y, et al. Down-regulation of A20 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. J Clin Immunol. 2012;32(6):1287–1291. doi: 10.1007/s10875-012-9764-2
  • Matmati M, Jacques P, Maelfait J, et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat Genet. 2011;43(9):908–912. doi: 10.1038/ng.874
  • de Matos AG, Ribeiro Junior HL, de Paula Borges D, et al. Interleukin-8 and nuclear factor kappa B are increased and positively correlated in myelodysplastic syndrome. Med Oncol. 2017;34(10):168. doi: 10.1007/s12032-017-1023-1